Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
A pre-wedding video showing Pune realtor Ketan Agarwal joyfully celebrating with his fiancée Siya Goyal and her parents has ...
Adam Omary’s op-ed (“The disability accommodation trap on college campuses,” Opinion, June 29) raises important questions, ...
The Transportation Security Administration is initiating a new screening program for crew members, and airlines are paying ...
Local AI inference at 32B-parameter quality, no cloud API required: University of Waterloo researchers released PAW on July 2 ...
Aging changes gut bacteria in mice, weakening communication between the intestines and the brain. Restoring that connection ...
Don't buy a "borrowed science" NAD supplement. Discover how Niagen Bioscience’s patented NR safely and efficiently boosts ...
Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...
The U.S. Army veteran-operated maker of advanced photonic solutions will support U.S. Army's night fighting capability ...
Reasons to be Cheerful reports that cycling improves focus in kids, especially those with ADHD, as seen in Spooner Middle School's successful Riding for Focus program.
LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...
David Gerbing from the School of Business at Portland State University introduces lessR, a tool designed to facilitate professional-quality data visualizations and data analysis without programming re ...